Uptrend Under Pressure 100
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 100/100 · 7 distribution days (SPY) Oct 26 Full briefing →
View
Simple research view

DGX · Quest Diagnostics Incorporated

$242.95 +0.44% Oct 26 close
Detected setup Wyckoff SOS · Setup Score 70/100

Stand aside — setup invalidated

Setup score 70, but distribution days reach 5 or more — stand aside until the condition resets.

2 independent risk warnings also present. Review before relying on the bullish setup.

Ask about DGX

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$DGX

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated is a large-cap Services to the Health Industry company in the Health Services sector with a market cap of $27B.

Health Services Services to the Health Industry stock Stage 2 · Advancing Base 1
$242.95 latest close
Market Structure
Trend structure: downtrend
Latest event: bos (bearish)
Support 189.72–191.31 · 5 touches · strong
Support 192.73–193.76 · 5 touches · strong
Support 173.51–174.48 · 3 touches · moderate
Support 200.94–201.00 · 3 touches · moderate
Support 213.20–214.40 · 3 touches · moderate
Join to Watchlist $DGX Share card
Verdict · setup score 70/100 · data Oct 26 close · latest session

Stand aside — setup invalidated

Setup score 70, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart
Recent price action · daily
$240AugSepOct$243

What would change this verdict

What needs to turn for this to become buyable — the top failing checks across the legend council:

  • Minervini 2. Quarterly EPS growth ≥ 25% — +3.3% QoQ
  • Minervini 2. ROE ≥ 17% — ROE 14.1%
  • O'Neil C: Quarterly EPS acceleration ≥ 25% — +3.3% QoQ
  • O'Neil L: RS rank ≥ 80 (IBD leadership) — RS rank 79
  • Weinstein Volume expansion above average — Volume ratio 0.91x
  • Weinstein Weekly price coiling (Stage 2 consolidation) — Tightening weekly range confirms base
Minority view — the council disagrees here
  • Minervini: watch Trend-template read: 9/12 pass; wait for the soft misses to improve.
  • O'Neil: avoid CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
  • Weinstein: watch Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
69 Strong
Legend Score · rates the stock Strong (69/100) — held back by eps growth

Our proprietary 0-100 rating — the answer to Wall Street's black-box scores. Five pillars, each computed from real scan data, each explained below in plain English.

  • Relative Strength (25%) 80
  • Trend Template (25%) 100
  • Institutional Footprint (20%) 67
  • EPS Growth (15%) 30
  • Quality (SMR-like) (15%) 44

RS rank 79: above-average strength. Trend template 8/8: price above rising 50/150/200-day lines — textbook uptrend structure. Institutional score 67: mild accumulation. EPS up +0% — growing, but below the 25% leadership bar. Quality 44: weak fundamentals (sales growth 30, return on equity 41, leverage 100). Updated 2026-10-27.

Earnings

Normal technical setup

Next earnings Thursday, October 22, 2026 Before market open Exact clock time not supplied by source

Deterministic evidence

Reported EPS 3.0 vs estimate 2.8931 · surprise +3.7%

DGX+0.44%
Sector proxy · XLV+0.00%
Broad market · SPY+0.71%
Same completed session window ending 2026-10-26. DGX was +0.44 points vs XLV. -0.27 points vs SPY.

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close+0.44% From the open-0.02% Range position61% GapNo gap
QQQ confirmationConfirming (+1.11%) SMH confirmationConfirming (+2.74%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $242.95 +0.4% Oct 26 close
52W High $248.84 2.4% below high
Wks Since High 5w
Base Depth 10.2%
RS Rank 56 percentile of scan
SMA 50 $237.77
Avg Vol 1,053,948
Rel Vol (Oct 26) 0.91× 1.00× on up days
More stats
52W Low $171.18
Tight Wks 1
Base B1
SMA 200 $210.77
RS Line vs High -3.1%
RS Line Slope +4.6% ▲
Group Rank #16/66
ADR% 2.5%
ATR(14) $6.41 (2.6%)
Vol Pace (live) N/A
A/D Days 11A / 8D
A/D Rating A
VDU Bars 0/10 d
Earnings past
Position in 52-week range 92ndpercentile of the 52-week range
$171.18low
$248.84high

DGX Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for DGX.

Create Free Account

Technical Analysis Report Card

$DGX · $242.95 · as of 2026-10-26 · multi-factor read
93
/ 100
Technicals 93/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$237.77 ↑
100-day$226.57 ↑
200-day$210.77 ↑
Bullish (50 > 200)

RSI (14)

Reading60.3 · Bullish

Bullish momentum — comfortably in buyer territory.

MACD (12/26/9)

StateBullish
Histogram+1.325

Bullish — MACD above its signal line and above zero. Histogram expanding.

Bollinger Bands (20,2)

%B / Width95% · 8.0%

Near the upper band — buyers in control.

Volume · Buyer vs Seller

Up/Down vol1.0 · Neutral
Rel volume0.91×
Pocket pivots · 10d2
5d vs 50d vol117%
Heavy vol up / down1 / 1

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

  • Pocket pivot 2 sessions ago — up-day volume beat every down day of the prior 10 sessions.
  • 1 heavy-volume up day vs 1 down in the last 20 sessions.

Support & Resistance

R · $248.0152-week high
Price · $242.95now
S · $232.28swing level
S · $227.54swing level
S · $201.00swing level

Fibonacci · Uptrend swing

23.6%$234.06
38.2%$224.92
50.0%$217.53
61.8%$210.15
78.6%$199.63

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for DGX — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice? Ask a Legend about DGX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
How to read the numbers: the setup score (70/100, in the verdict band) rates this trade setup. Each legend's A–D grade rates the same setup against that legend's own checklist — so a high score next to a C grade is not a contradiction. The setup can be strong without fitting that legend's style. When the council disagrees, the verdict band breaks the tie.

Council consensus: 7 of 9 legends are Watching — building, not yet a confirmed buy.
Minervini Watch B Trend-template read: 9/12 pass; wait for the soft misses to improve.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $242.95, MA150 $215.76, MA200 $210.77
1.2 150-day MA > 200-day MAMA150 $215.76 vs MA200 $210.77
Failing evidence
2. Quarterly EPS growth ≥ 25%+3.3% QoQ
2. ROE ≥ 17%ROE 14.1%
9/12 checks
Method → Playbook → Ask →
O'Neil Avoid D CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

partialRule check says AVOID (2/8 checks passed) — CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high2.4% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.64%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+3.3% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 79
2/8 checks
Method → Playbook → Ask →
Weinstein Watch C Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.

mediumClassic Stage 2 advancing phase — strong weekly trend confirms uptrend. This is Weinstein's sweet spot: buy and hold while price remains above the 30-week MA.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $242.95 vs MA200 $210.77
Failing evidence
Volume expansion above averageVolume ratio 0.91x
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
5/7 checks
Method → Playbook → Ask →
dennis Watch C Turtle read: no breakout yet. Price is pressing the 20-day high. The system waits for the print; it never anticipates.
Passing evidence
No breakdown below the 20-day channel20-day low $223.50
Volatility-unit sizing (1N ≈ 1% of equity)1N = $6.12 (2.52% of price); the Turtles size 1 unit so a 1N move ≈ 1% of equity, making the 2N stop ≈ 2% equity risk
Failing evidence
S1: 20-day Donchian breakoutNot confirmed
S2: 55-day Donchian breakoutNot confirmed
5/7 checks
Method → Playbook → Ask →
zanger Avoid C Zanger read: a hard gate is broken — either the pattern is not one of his six, or the entry is more than 5% past the breakout. He would not touch this.
Passing evidence
Not extended (≤5% above the breakout point)Measured as passing
Partial-profit plan: sell 20-30% at +15-20%Scale 20-30% at $279.39-$291.54; trail the rest
Failing evidence
Named Zanger pattern onlyWyckoff SOS is not one of Zanger's six
Breakout volume 1.5-2.0x averageData unavailable
4/6 checks
Method → Playbook → Ask →
zweig Watch D Zweig read: part of his screen passes but not all: EPS growth above the market (≥15% QoQ); Insider buying — wait for the full growth screen before treating this as a Zweig setup.
Passing evidence
Reasonable price for the growth (P/E ≤ 35)Trailing P/E 27.8x — no PEG or forward P/E stored
Price strength (RS ≥ 70)RS score 79 — Zweig buys strength, not bargains
Failing evidence
EPS growth above the market (≥15% QoQ)+3.3% QoQ — Zweig wants growth above the S&P average
Insider buyingNo insider buying flagged
4/8 checks
Method → Playbook → Ask →
Livermore Watch B Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.
Passing evidence
Price$242.95
Relative strengthRS 79
Failing evidence
Volume vs average0.91x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Darvas Watch B Box-theory read: constructive evidence is present, but volume vs average is unresolved.

mediumStock is at the top of its box — Darvas would wait for a decisive breakout on volume.

Passing evidence
Price$242.95
Relative strengthRS 79
Failing evidence
Volume vs average0.91x
Box top broken on heavy volumeNot confirmed
4/6 checks
Method → Playbook → Ask →
Wyckoff Watch B Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

mediumSign of Strength — breakout above trading range on expanding volume. Accumulation phase complete, markup beginning. RS 79.

Passing evidence
Price$242.95
Relative strengthRS 79
Failing evidence
Volume vs average0.91x
Sign of Strength confirmed on expanding volume0.91x average volume — needs ≥1.4x
4/6 checks
Method → Playbook → Ask →
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.

Unlock Base & Breakout Tracking
RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising
121RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +10 A
A: 18 D: 8 Net: +1065 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 3/7 met
C 3/7 criteria
Separate score from the Minervini Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
✗ EPS acceleration ≥25% QoQ +3%
✗ Revenue growth ≥20% YoY +12%
✓ Gross margin ≥30% 33%
✗ ROE ≥17% 14%
✗ RS rating ≥80 (leadership) 79
✓ Stage 2 uptrend (Weinstein) Stage 2
✓ Within 25% of 52W high -2.4%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

Wyckoff SOS Historical replay: +20% before −8% within 40 sessions: 15% (n=225) · source bars 2024-11-01–2026-10-26 · avg +0.4% per setup (+0.05R) ⚠ Volatility widening into breakout ⚠ Bearish RSI divergence
70 setup score
RS Score 79
Trend template 8/8 ✓
CANSLIM 73.5* (B)
range low: 190.736 range high: 239.083 range pct: 0.253 sos thrust: 0.018 sos vol ratio: 1.859 sos bars ago: 2 near lps: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS · schematic

SOS: breakout above range_high=239.08, thrust=1.8%, vol=1.9x avg, lps=near, 2 bars ago | Strong trend (8/8) | Good RS (79) | High-confidence pattern (75%) | Stage 2 | Readiness 72/100 (watch) | CANSLIM 73.5 (B) | ⚠ Volatility widening into breakout; Bearish RSI divergence

Ask a Legend ▾
Pocket Pivot ⚠ Bearish RSI divergence ⚠ Not actionable yet
55 setup score
RS Score 79
Trend template 8/8 ✓
CANSLIM 71.7* (B)
volume ratio: 1.67 near moving avg: ✓ upper close: ✓ shooting star: ✗ price past buy range: ✗ vol beats down: ✓ bars since signal: 2 signal close: 243.28 validation reason: valid pocket-pivot multi tf evaluated: ✓ multi tf reason: weekly trend template 8/8 confirmed + no fresh 13-week low
Why This Setup?
Pocket Pivot · schematic

Up vol 1,686,003 vs max down vol 1,009,583 (near MA), upper_close=yes, bars_ago=2 | Strong trend (8/8) | Good RS (79) | High-confidence pattern (80%) | Stage 2 | Readiness 63/100 (early) | CANSLIM 71.7 (B) | ⚠ Bearish RSI divergence; Not actionable yet

Ask a Legend ▾
The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

4/7 universals met
  • A relative-strength leader — not met RS rank 56 — laggard
  • Clear of earnings — not met in -5 days — event risk
  • Volume confirms — partly met 0.9× average — light
  • Asymmetric reward — met Met — levels are a Pro detail
  • In a confirmed uptrend — met Stage 2 · Trend template 8/8
  • Not chasing (in range) — met Met — levels are a Pro detail
  • Risk is defined — met Met — levels are a Pro detail
Why these seven? → The Universal Edge

Minervini Trend Template

8/8 ✓

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $242.95 vs SMA150 $215.76 / SMA200 $210.77
SMA 150 above SMA 200 SMA150 $215.76 vs SMA200 $210.77
SMA 200 trending up Slope +5.70 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $237.77
Price above SMA 50 $242.95 vs SMA50 $237.77
30%+ above 52-week low +41.9% from $171.18
Within 25% of 52-week high -2.4% from $248.84
RS score above 70 RS 79

Fundamentals

52W Range
92%
Mkt Cap SEC
26.7B
EPS QoQ
+3%
Rev YoY
+12%
ROE
14%
Gross Margin
33%
D/E
0.82
EPS TTM
$8.75
P/E TTM
27.8x
Float
110M
Insider
No Buy

Company

Company profile
Quest Diagnostics Incorporated
DGX · NYSE · Health Services · Services to the Health Industry
Track all markets on TradingView
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 73.5* CANSLIM * disqualified on C, M
C · Curr. EPS
60
A · Annual EPS
72
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
79
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
78
W. Support
$186.23
W. Resist
$248.84
Weekly Structure

Scan History

20× streak
Oct 23: 70 (Pocket Pivot)Oct 26: 70 (Pocket Pivot)Oct 27: 70 (Wyckoff SOS)70
Oct 27
Wyckoff SOS ✓ Gate
70
Oct 26
Pocket Pivot ✓ Gate
70 0.0%
Oct 23
Pocket Pivot ✓ Gate
70 +0.4%

Latest News

Headlines for DGX
Loading headlines…

Get the full picture on DGX

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial